The chemotherapy of leprosy. Part 1.
Ellard
G A
GA
D000818:Animals; D002991:Clofazimine / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*; D003622:Dapsone / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*; D004352:Drug Resistance, Microbial; D004359:Drug Therapy, Combination; D005000:Ethionamide / Q000627:therapeutic use; D006801:Humans; D007918:Leprosy / Q000188:drug therapy*; D009166:Mycobacterium leprae / Q000187:drug effects; D011515:Prothionamide / Q000627:therapeutic use; D012293:Rifampin / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*
D011515:Prothionamide; D003622:Dapsone; D002991:Clofazimine; D005000:Ethionamide; D012293:Rifampin